Search - tctmd.com

Displaying 21 - 40 of 147

Sort: Relevancy | Date

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

Caitlin E. Cox

November 06, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Caitlin E. Cox

October 31, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

News Conference News EACTS 2022

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Michael O'Riordan

October 07, 2022

News Daily News

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Michael O'Riordan

October 07, 2022

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Caitlin E. Cox

October 03, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

Presentation TCT 2022

Con

Presenter: Nihar Desai

September 19, 2022

Presentation TCT 2022

Pro

Presenter: Babar Basir

September 19, 2022

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From OCT Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

Presentation TCT 2022

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

Presenter: Toshiro Shinke

September 19, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

Presenter: Sanjit Jolly

September 19, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Factor XI Inhibition

Presenter: C. Michael Gibson

September 19, 2022

Presentation TCT 2022

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

Presenter: William Fearon

September 19, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

Advertisement

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

November 2022 News Roundup

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

New Biomarker-Based Risk Score Performs Well in ACS

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

October 2022 News Roundup

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Con

Pro

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

New and Emerging Pharmacology for ACS: Factor XI Inhibition

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content